Objective: To assess the burden of renal cell carcinoma (RCC) in epidemiologic and economic terms. Methods: Retrospective, naturalistic longitudinal study on the occurrence, outcomes and cost of RCC using an administrative database. We selected residents of Friuli-Venezia-Giulia (FVG), a North-eastern Region of Italy, who had a RCC first hospital admission during the period 2000-2004, and we followed them up until: 30th June 2005, death or transfers. Direct medical costs were quantified in the perspective of FVG Regional Health Service. Results: We enrolled 1358 patients (63% male), the 18.8% presenting a metastatic-stage, leading to a crude incidence of 23/100.000 person-years. During the follow-up, 76% of the metastatic patients and 21% of the non-metastatic patients died. Total health care costs per-patient over the maximum of follow-up were 16,090€ for the localised stage group and 17,656€ in the metastatic-stage group. Discussion: RCC imposes a significant epidemiologic and economic burden to the healthcare-system and the society. © 2008 Elsevier Ltd. All rights reserved.

Mantovani, L., Morsanutto, A., Tosolini, F., Mustacchi, G., Esti, R., Belisari, A., et al. (2008). The burden of renal cell cancer: A retrospective longitudinal study on occurrence, outcomes and cost using an administrative claims database. EUROPEAN JOURNAL OF CANCER. SUPPLEMENT, 6(14), 46-51 [10.1016/j.ejcsup.2008.06.013].

The burden of renal cell cancer: A retrospective longitudinal study on occurrence, outcomes and cost using an administrative claims database

Mantovani LG
Primo
;
2008

Abstract

Objective: To assess the burden of renal cell carcinoma (RCC) in epidemiologic and economic terms. Methods: Retrospective, naturalistic longitudinal study on the occurrence, outcomes and cost of RCC using an administrative database. We selected residents of Friuli-Venezia-Giulia (FVG), a North-eastern Region of Italy, who had a RCC first hospital admission during the period 2000-2004, and we followed them up until: 30th June 2005, death or transfers. Direct medical costs were quantified in the perspective of FVG Regional Health Service. Results: We enrolled 1358 patients (63% male), the 18.8% presenting a metastatic-stage, leading to a crude incidence of 23/100.000 person-years. During the follow-up, 76% of the metastatic patients and 21% of the non-metastatic patients died. Total health care costs per-patient over the maximum of follow-up were 16,090€ for the localised stage group and 17,656€ in the metastatic-stage group. Discussion: RCC imposes a significant epidemiologic and economic burden to the healthcare-system and the society. © 2008 Elsevier Ltd. All rights reserved.
Articolo in rivista - Articolo scientifico
rcc, renal cell cancer, bod
English
2008
6
14
46
51
none
Mantovani, L., Morsanutto, A., Tosolini, F., Mustacchi, G., Esti, R., Belisari, A., et al. (2008). The burden of renal cell cancer: A retrospective longitudinal study on occurrence, outcomes and cost using an administrative claims database. EUROPEAN JOURNAL OF CANCER. SUPPLEMENT, 6(14), 46-51 [10.1016/j.ejcsup.2008.06.013].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/282171
Citazioni
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 5
Social impact